TABLE 2.
Univariate and multivariate analysis of disease‐free survival in 89 CRC patients
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR (95% CI) | P‐value | HR (95% CI) | P‐value | |
| Age (yr) | 0.904 (0.311‐2.610) | .471 | ||
| Gender | 1.301 (0.732‐2.324) | .617 | ||
| Tumor location | 0.468 (0.521‐1.148) | .543 | ||
| T classification | 2.313 (1.475‐4.832) | .004* | 1.389 (1.323‐3.410) | .031* |
| N classification | 2.453 (1.512‐3.022) | <.001* | 0.315 (0. 710‐1.314) | .338 |
| M classification | 8.216 (3.474‐11.307) | <.001* | 6.732 (3.391‐10.137) | <.001* |
| AJCC stage (III‐IV vs I‐II) | 3.766 (2.535‐12.786) | <.001* | 3.208 (1.269‐9.472) | .012* |
| Differentiation | 0.724 (0.434‐1.734) | .465 | ||
| Recurrence | 6.013 (3.138‐12.325) | <.001* | 4.215 (1.823‐13.105) | <.001* |
| lncARSR | 4.736 (1.079‐8.018) | <.001* | 2.484 (1.132‐6.232) | .028* |
Abbreviations: CI, confidence interval; HR, hazard ratio.
*
P < .05 indicate that the 95% CI of HR was not including 1.